These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1592278)

  • 1. Gynecologic complications associated with long-term adjuvant tamoxifen therapy for breast cancer.
    Wolf DM; Jordan VC
    Gynecol Oncol; 1992 May; 45(2):118-28. PubMed ID: 1592278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of tamoxifen in the treatment and prevention of breast cancer.
    Jordan VC
    Curr Probl Cancer; 1992; 16(3):129-76. PubMed ID: 1582240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of tamoxifen on the endometrium.
    Barakat RR
    Oncology (Williston Park); 1995 Feb; 9(2):129-34; discussion 139-40, 142. PubMed ID: 8771096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gynecologic monitoring of tamoxifen treatment of breast cancer].
    Le Bouedec G; Pingeon JM; Fondrinier E; Kauffmann P; Dauplat J
    Rev Fr Gynecol Obstet; 1995; 90(7-9):379-82. PubMed ID: 7481445
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adjuvant therapy of breast cancer with tamoxifen and endometrial carcinoma].
    Mignotte H; Sasco AJ; Lasset C; Saez S; Rivoire M; Bobin JY
    Bull Cancer; 1992; 79(10):969-77. PubMed ID: 1292764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer.
    Fornander T; Hellström AC; Moberger B
    J Natl Cancer Inst; 1993 Nov; 85(22):1850-5. PubMed ID: 8230266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen: toxicities and drug resistance during the treatment and prevention of breast cancer.
    Jordan VC
    Annu Rev Pharmacol Toxicol; 1995; 35():195-211. PubMed ID: 7598491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of gynecologic services in women with breast cancer receiving hormonal therapy.
    Wright JD; Desai VB; Chen L; Burke WM; Tergas AI; Hou JY; Accordino M; Ananth CV; Neugut AI; Hershman DL
    Am J Obstet Gynecol; 2017 Jul; 217(1):59.e1-59.e12. PubMed ID: 28341383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gynecologic complications associated with prolonged use of tamoxifen to breast neoplasms].
    Gálvez Asun J
    Rev Chil Obstet Ginecol; 1993; 58(2):176. PubMed ID: 8209048
    [No Abstract]   [Full Text] [Related]  

  • 10. Symptoms associated with tamoxifen treatment in postmenopausal women.
    Love RR; Cameron L; Connell BL; Leventhal H
    Arch Intern Med; 1991 Sep; 151(9):1842-7. PubMed ID: 1888251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).
    Mignotte H; Lasset C; Bonadona V; Lesur A; Luporsi E; Rodier JF; Cutuli B; Lasry S; Mauriac L; Granon C; Kerr C; Giard S; Hill C; de Lafontan B; de Gislain C; D'Anjou J; Fondrinier E; Lefeuvre C; Parache RM; Chauvin F
    Int J Cancer; 1998 May; 76(3):325-30. PubMed ID: 9579567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
    Katase K; Sugiyama Y; Hasumi K; Yoshimoto M; Kasumi F
    Cancer; 1998 May; 82(9):1698-703. PubMed ID: 9576291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A lower incidence of gynecologic adverse events and interventions with anastrozole than with tamoxifen in the ATAC trial.
    Duffy SR; Distler W; Howell A; Cuzick J; Baum M
    Am J Obstet Gynecol; 2009 Jan; 200(1):80.e1-7. PubMed ID: 19019322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial carcinoma in tamoxifen-treated breast cancer patients.
    Spinelli G; Bardazzi N; Citernesi A; Fontanarosa M; Curiel P
    J Chemother; 1991 Aug; 3(4):267-70. PubMed ID: 1779263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.
    Fisher B; Costantino JP; Redmond CK; Fisher ER; Wickerham DL; Cronin WM
    J Natl Cancer Inst; 1994 Apr; 86(7):527-37. PubMed ID: 8133536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iatrogenic endometrial megapolyps in women with breast carcinoma.
    Berezowsky J; Chalvardjian A; Murray D
    Obstet Gynecol; 1994 Oct; 84(4 Pt 2):727-30. PubMed ID: 9205466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term adjuvant tamoxifen therapy for breast cancer.
    Jordan VC
    Breast Cancer Res Treat; 1990 May; 15(3):125-36. PubMed ID: 2196941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen and endometrial cancer.
    Segna RA; Dottino PR; Deligdisch L; Cohen CJ
    Mt Sinai J Med; 1992 Oct; 59(5):416-8. PubMed ID: 1435840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gynecologic tumors in tamoxifen-treated women with breast cancer.
    Cohen I; Altaras MM; Beyth Y
    Obstet Gynecol; 1994 Jan; 83(1):158-9. PubMed ID: 8272299
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen.
    Bergman L; Beelen ML; Gallee MP; Hollema H; Benraadt J; van Leeuwen FE
    Lancet; 2000 Sep; 356(9233):881-7. PubMed ID: 11036892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.